Bride 'Blew Her Entire Savings.' Now, She Expects Her Sister to Help Pay for Her 'Lavish' Wedding
In a post on Reddit's "Wedding Shaming" forum, the woman shared that her sister has asked to use her savings to fund her wedding
"She knows I have a decent chunk of change saved and she's been dropping not-so-subtle hints about how I'm 'so responsible with my money' and 'don't have a mortgage yet' so surely I can spare some cash for her big day," the Reddit user wroteA woman wonders whether she's wrong to refuse to help her sister pay for her "dream wedding."
In a post on Reddit's "Wedding Shaming" forum, the 30-year-old woman opened up about her sister's "serious main character energy when it comes to her wedding."
"The kicker — she expects me to foot a significant chunk of the bill after she blew her entire savings — $25k — on a ridiculous MLM [multilevel marketing] scheme," she explained.
According to the OP (original poster), her sister, a 32-year-old named Chloe, has a history of being "terrible with money."
"Think impulsive buys loans for trips, the whole nine yards," the OP wrote. "Meanwhile, I've been diligently saving every penny for a down payment on a house. Our financial approaches are polar opposites."
"About a year and a half ago, Chloe got completely sucked into one of those 'boss babe' wellness drink MLMs," she continued, referring to the business model where participants earn money from both selling products or services and recruiting others into the network. According to the Federal Trade Commission, many MLM companies are illegal pyramid schemes.
"I tried to warn her gently at first, then more forcefully as she sank more and more cash into inventory and training. She was convinced she'd be a millionaire. Spoiler alert: she's not," the OP added. "She flushed her entire $25k savings down the drain and is now financially back at square one."
According to the Redditor, Chloe is engaged and has plans for a "massive, fairytale wedding — the kind that easily costs $50k+" — and she's asked her sister for help paying for the lavish event.
"She knows I have a decent chunk of change saved and she's been dropping not-so-subtle hints about how I'm 'so responsible with my money' and 'don't have a mortgage yet' so surely I can spare some cash for her big day," the OP wrote.
Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories.
Eventually, the sister "straight-up asked" for the money, and the OP was taken aback by her justifications for the bold request.
" 'You know,' she said, 'if you even threw in like 10 grand it would make such a huge difference. You don't really need all that house money right this second and this is my one shot at the wedding I've always pictured,' " the OP wrote, recounting the conversation.
The OP said she absolutely "lost it" after this request and promptly shut it down.
"I told her, 'Chloe there is NO WAY I'm paying for your wedding. You literally flushed your savings down the drain on a scam, even though everyone told you not to and now you expect me to bankroll your fantasy. My savings are for MY future, not to bail you out of your past mistakes,' " she said.
Her sister got upset, calling the OP "selfish" and "unsupportive." The sisters' mom also took Chloe's side, telling her other daughter: "Family helps family."
"Honestly, I feel a little bad for making her cry and I do love my sister," the OP admitted. "But I also feel like I'm being put in an impossible position. She made her bed and now she expects me to pay for the luxury sheets."
In the comments section, readers were quick to take the OP's side, agreeing that she shouldn't have to fork over her hard-earned savings just because she isn't getting married or buying a home right now.
"Any time she brings it up, just remind her that 'no' is your final answer," one person advised. "If she wants a $50k wedding, then she and her fiancé had better start saving that."
"I find it extremely audacious that you are being asked to give up or push back your dream because of your sister's poor financial decisions," another commenter said. "She needs to learn to live within her means. And right now, those means do not extend to a $50k wedding."
Read the original article on People
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
How To Earn $500 A Month From Applied Materials Stock Ahead Of Q3 Earnings
Applied Materials, Inc. (NASDAQ:AMAT) will release earnings results for the third quarter after the closing bell on Thursday, Aug. 14. Analysts expect the tech company to report quarterly earnings at $2.36 per share, up from $2.12 per share in the year-ago period. Applied Materials—a supplier of chipmaking equipment to Texas Instruments' U.S. factories— projects to report quarterly revenue at $7.22 billion, compared to $6.78 billion a year earlier, according to data from Benzinga Pro. Some investors may be eyeing potential gains from the company's dividends. The company currently offers an annual dividend yield of 0.97%. That's a quarterly dividend amount of 46 cents per share ($1.84 a year). To figure out how to earn $500 monthly from Applied Materials, we start with the yearly target of $6,000 ($500 x 12 months). Next, we take this amount and divide it by Applied Materials' $1.84 dividend: $6,000 / $1.84 = 3,261 shares. So, an investor would need to own approximately $619,688 worth of Applied Materials, or 3,261 shares to generate a monthly dividend income of $500. Assuming a more conservative goal of $100 monthly ($1,200 annually), we do the same calculation: $1,200 / $1.84 = 652 shares, or $123,900 to generate a monthly dividend income of $100. View more earnings on AMAT Note that dividend yield can change on a rolling basis. The dividend payment and the stock price both fluctuate over time. The dividend yield is calculated by dividing the annual dividend payment by the current stock price. As the stock price changes, the dividend yield will also change. For example, if a stock pays an annual dividend of $2 and its current price is $50, its dividend yield would be 4%. However, if the stock price increases to $60, the dividend yield would decrease to 3.33% ($2/$60). Conversely, if the stock price decreases to $40, the dividend yield would increase to 5% ($2/$40). Further, the dividend payment itself can also change over time, which can also impact the dividend yield. If a company increases its dividend payment, the dividend yield will increase even if the stock price remains the same. Similarly, if a company decreases its dividend payment, the dividend yield will decrease. AMAT Price Action: Shares of Applied Materials rose by 0.8% to close at $190.03 on More: Image: Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? APPLIED MAT (AMAT): Free Stock Analysis Report This article How To Earn $500 A Month From Applied Materials Stock Ahead Of Q3 Earnings originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.
Yahoo
25 minutes ago
- Yahoo
Tapestry shares sink 16% after Coach owner posts underwhelming annual outlook
- Shares of Tapestry (NYSE:TPR) plunged by more than 16% in premarket U.S. trading on Thursday after the fashion group unveiled income estimates for its current fiscal year that underwhelmed Wall Street expectations. The Coach-owner also flagged that it incurred charges that decreased its pre-tax income for the April to June quarter by $872 million, adding that these were linked to a decline in both current and future expected cash flows due to a tariff-driven increase in operating costs. Tapestry, which sources much of its goods from countries like Vietnam and the Philippines that have been hit by elevated U.S. tariffs, warned that the duties would also lead to a headwind of about 230 basis points -- or $160 million -- in its fiscal 2026 income margin. "[T]his outlook reflects the timing of policy implementation, product sell-through, and mitigating actions underway," Tapestry said in a statement, although it noted that it expects to offset these "incremental tariffs and duties over time." Against this backdrop, the firm predicted that it would post full-year adjusted earnings per share of $5.30 to $5.45, compared to Bloomberg consensus estimates of $5.49. Revenue, meanwhile, is tipped be up to $7.2 billion, versus projections of $7.12 billion, thanks partially to a tailwind from foreign currency effects. Accessible luxury brands, such as Tapestry, have been gaining some momentum as the tariffs fuel broader economic uncertainty that is leading some shoppers -- particularly younger ones -- to shy away from high-end items and search for cheaper alternatives. Fourth-quarter net sales rose by 8.3% compared to a year ago to $1.72 billion, topping estimates. Adjusted per-share profit came in at $1.04. Related articles Tapestry shares sink 16% after Coach owner posts underwhelming annual outlook Victoria's Secret Exposed: The Warning Sign Behind the Stock's 52% Collapse Risks Rising? Smart Money Dodged 46%+ Drawdowns on These High-Flying Names Sign in to access your portfolio
Yahoo
25 minutes ago
- Yahoo
MiNK Therapeutics Reports Clinical and Strategic Milestones and Second Quarter 2025 Results
Cash runway extended to deliver clinical program in GVHD and Ph2 results in 2L Gastric Cancer Department of Defense STTR Grant to advance INKTs in GVHD announced; program advancing New clinical grant awarded to launch AgenT-797 in GvHD clinical trial; target initiation 2H2025 NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic, off-the-shelf invariant natural killer T (iNKT) cell therapies, today announced financial results for the second quarter ended June 30, 2025, and provided a business update highlighting major clinical achievements, a strengthened balance sheet, and expanded funding to advance both oncology and immunology programs. 'In Q2, we demonstrated the power of our platform with high impact clinical results, publication of key clinical findings, and competitive, non-dilutive, federal funding,' said Jennifer Buell, Ph.D., President and Chief Executive Officer of MiNK Therapeutics. 'Since quarter-end, we further strengthened our financial position that extends our runway beyond mid-2026. With our cash position, coupled with two separate non-dilutive grants for the clinical advancement of allo-INKTs in GvHD — we can achieve substantial clinical program advancements.' Highlights from Q2 2025 Durable Complete Remission in Metastatic Testicular Cancer: Nature's Oncogene publication of a landmark case of a patient with treatment-refractory metastatic testicular cancer who achieved a durable complete remission following a single infusion of agenT-797 (allo-INKTs) in combination with checkpoint blockade. The patient remains disease-free more than two years post-treatment. Strengthened Balance Sheet: Increased cash reserves extending runway beyond mid-2026 to advance clinical programs. Department of Defense STTR Grant Awarded for GvHD: Competitive DOD STTR grant awarded to advance development of iNKTs for graft-versus-host disease (GvHD) prevention and treatment; program launched. NEW Clinical Grant Awarded for GvHD: Additional clinical competitive grant awarded to initiate a first-in-human clinical trial of iNKTs in GvHD, with trial initiation targeted in 2H2025. Progress in Phase 2 Gastric Cancer Study: Phase 2 trial of agenT-797 in second-line gastric cancer anticipated additional clinical readouts in 2025. Peer-Reviewed Review of iNKT Cell Therapy: A Frontiers in Immunology featured MiNK's platform, highlighting iNKT cells' can remodel the tumor microenvironment and overcome therapeutic resistance, showcasing CAR-iNKTs, such as MiNK-215 as a next-generation solution for solid tumors. Financial Highlights Cash Position: MiNK ended Q2 2025 with approximately $1.6 million in cash and cash equivalents and subsequently raised $13 million through equity sales, providing expected runway into mid-2026. Net Loss: Net loss for Q2 2025 was $4.2 million, or $1.06 per share, compared to $2.7 million, or $0.73 per share for Q2 2024. For the first half of 2025, net loss was $7 million, or $1.76 per share compared to $6.5 million or $1.82 per share for the first half of 2024. Current period results reflect ongoing activity supporting our agent-797 programs and non-cash expenses including the impact of repricing of certain equity awards. Summary Consolidated Financial Information Condensed Consolidated Balance Sheet Data (in thousands) (unaudited) June 30, 2025 Cash and cash equivalents $ 1,682 Cash raised since quarter end 13,012 Other Financial Information (in thousands) (unaudited) Three months ended June 30, Six months ended June 30, 2025 2024 2025 2024 Cash used in operations $ 1,569 $ 2,291 $ 2,910 $ 4,833 Non-cash expenses 1,501 491 2,336 1,141 Net loss 4,237 2,702 7,004 6,515 Net loss per share 1.06 0.73 1.76 1.82 Conference Call and Webcast Information MiNK will host a conference call and webcast on August 14, 2025, at 8:30 a.m. ET. To access the live call, please dial (800) 715-9871 (U.S.) or (646) 307-1963 (International) and reference conference ID 1149380. A live webcast and replay will be available in the Events & Presentations section of MiNK's investor website at About MiNK Therapeutics MiNK Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. MiNK is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery. The company is headquartered in New York, NY. For more information, visit or @MiNK_iNKT. Information that may be important to investors will be routinely posted on our website and social media channels. Forward Looking Statements This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the federal securities laws. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially. These forward-looking statements are subject to risks and uncertainties, including the factors described under the Risk Factors section of the most recent Form 10-K, Form 10-Q. MiNK cautions investors not to place considerable reliance on the forward-looking statements contained in this release. These statements speak only as of the date of this press release, and MiNK undertakes no obligation to update or revise the statements, other than to the extent required by law. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. Investor Contact917-362-1370 | investor@ Contact781-674-4422 | communications@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
